Osmetech plc Newsroom - Profile and News Archive

Osmetech plc | Osmetech plc, Minerva Biotechnologies Corporation, James White, Harvard SAM IP, self-assembling monolayer technology, nanoparticle technology, near patient testing market, functionalized attachment of molecules to surfaces and reduce nonspecific aggregation events, LSE AIM OMH

Engage with Osmetech plc


RSS News Feed for Osmetech plc

Press Releases from Osmetech plc :

Osmetech Licenses Self-Assembling Monolayer (SAM) Technology to Minerva Biotechnologies Corporation

PASADENA, Calif. – June 18 (SEND2PRESS NEWSWIRE) — Osmetech plc (LSE, AIM; OMH) today announced that it has granted a non-exclusive research license to Waltham, Massachusetts, US-based Minerva Biotechnologies Corporation (‘Minerva’) for use of Osmetech’s self-assembling monolayer (SAM) technology in conjunction with Minerva’s proprietary nanoparticle technology.

Osmetech Licenses Roche Hot Start(R) Polymerase Technology

PASADENA, Calif. – June 5 (SEND2PRESS NEWSWIRE) — Osmetech plc (AIM; LSE: OMH) today announced that it has been granted a non-exclusive worldwide diagnostics license from Swiss-based F. Hoffman LaRoche Ltd and its US affiliate Roche Molecular Systems Inc. (collectively ‘Roche’) to use Hot Start(R) polymerase technology in Osmetech nucleic acid diagnostic assays.